Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma insulin concentrations such as those observed during the present insulin/glucose or glucose infusion studies, are known to completely suppress hepatic glucose production (27); thus, under these conditions, total glucose uptake is equal to exogenous glucose infusion.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [27]
In the citing paper
“Notably, insulin resistance is also associated with a decreased ability to suppress lipolysis in adipose tissue and altered fatty acid oxidation.50,51”
From The effects of sleep disruption on metabolism, hunger, and satiety, and the influence of psychosocial stress and exercise: A narrative review (2024) · cites this paper as [51]
In the citing paper
“In lean healthy individuals insulin stimulates glucose uptake into skeletal muscle in a dose-dependent manner, with a half-maximal effect (EC50) at a plasma insulin concentration ~60 μU/mL [21].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“Using the gold standard euglycemic hyperinsulinemic clamp technique to quantify insulin-stimulated glucose uptake, they demonstrated that both lean and obese T2DM subjects have marked decrease (>50%) in whole body glucose disposal during the insulin clamp.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“During the postabsorptive state, the plasma insulin concentration is low. Since the plasma insulin concentration is the principal factor that restrains lipolysis in adipocytes [21] and stimulates glucose uptake in skeletal muscle [21], during the fasting state, muscle glucose uptake is low and the plasma FFA concentration is elevated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“More than 20 years ago Randle and co-workers introduced the concept of substrate competition, whereby enhanced availability and oxidation of FFA leads to an impairment in glucose oxidation (17).”
BackgroundImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Since CPT I is inhibited by both insulin and malonyl-CoA, which is generated by condensation of acetyl-CoA (56), the insulin-mediated decline in FFA oxidation could have been due to a direct effect of the hormone on CPT I.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 2×
“in insulin-mediated glucose metabolism affects both hepatic and peripheral tissues, primarily muscle (1-6).”
BackgroundSelf-citationEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationRadioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Cited by
Items 501–600 of 812
Glans, F., Eriksson, K., Segerström, Å. B., Thorsson, O., Wollmer, P., & Groop, L. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.018 · Cited by 25
Self-citationZhang, K., Zhu, H., Wang, L., Yang, H., Pan, H., & Gong, F. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01372-9 · Cited by 20
Sood, V., Bhansali, A. K., Mittal, B. R., Singh, B., Marwaha, N., Jain, A., & Khandelwal, N. K. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i7.381 · Cited by 23
Rittig, N. F., Svart, M. V., Jessen, N., Møller, N., Møller, H. J., & Grønbæk, H. (2018) · Endocrine Connections · doi:10.1530/ec-17-0296 · Cited by 22
First approved inhaled insulin therapy for diabetes mellitus
Jani, R., Triplitt, C. L., Reasner, C. A., & DeFronzo, R. A. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.1.63 · Cited by 21
Self-citationTripathy, D., Lindholm, E., Isomaa, B., Saloranta, C., Tuomi, T., & Groop, L. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2003 · Cited by 20
“The etiology of the remaining 60–65% of the common form of type 2 diabetes remains a topic of controversy (2, 5, 10).”
BackgroundPathogenesis of obesity and diabetes mellitus: insights provided by indirect calorimetry in humans
Perseghin, G. (2001) · Acta Diabetologica · doi:10.1007/s005920170023 · Cited by 24
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 25
Secretion of Insulin in Response to Diet and Hormones
Elizabeth Mann 1, M. S. 2. (2020) · doi:10.3998/panc.2020.16 · Cited by 25
McLaughlin, T., Yee, G., Glassford, A. J., Lamendola, C. A., & Reaven, G. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.008 · Cited by 19
“These findings are consistent with earlier findings by Groop, et al (21) who showed that plasma FFA concentrations and turnover over are highly correlated.”
ResultVardeny, O., Uno, H., Braunwald, E., Rouleau, J. L., Gersh, B. J., Maggioni, A. P., DOMANSKI, M. J., Pfeffer, M. A., & Solomon, S. D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.064 · Cited by 21
Reyes, F. S. L. G. D., Mamaril, A. C. C., Matias, T. J. P., Tronco, M. K. V., Samson, G. R., Javier, N. D., Fadriquela, A., Antonio, J. M., & Sajo, M. E. J. (2021) · Processes · doi:10.3390/pr9111876 · Cited by 22
“Fat buildup in the liver of patients who have NAFLD can be caused by abnormal levels of free fatty acids (FFA) in the blood [43].”
BackgroundRiis, S., Møller, A. B., Dollerup, O. L., Høffner, L., Jessen, N., & Madsen, K. (2019) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13541 · Cited by 22
Lack of association between central adiposity and lipaemia in UK Sikh men
Lovegrove, J. A., Brady, L. M., Lesauvage, S. V., Lovegrove, S. S., Minihane, A. M., & Williams, C. M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802384 · Cited by 18
The Hyperglycemic Effect of S-Nitrosoglutathione in the Dog
McGowder, D., Ragoobirsingh, D., & Dasgupta, T. P. (1999) · Nitric Oxide · doi:10.1006/niox.1999.0254 · Cited by 18
Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism
Chambrier, C., Picard, S., Vidal, H., Cohen, R., Riou, J. P., & Beylot, M. (1990) · Metabolism · doi:10.1016/0026-0495(90)90311-y · Cited by 20
Doctors’ views and strategies to improve patients’ adherence to medication
Yfantopoulos, J., Protopapa, M., Chantzaras, A. E., & Yfantopoulos, P. (2021) · HORMONES · doi:10.1007/s42000-021-00294-2 · Cited by 18
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
Popovic, D. S., Παπάνας, Ν., Stoian, A. P., Rizvi, A. A., Janež, A., & Rizzo, M. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01170-3 · Cited by 18
“Excess inflammation impacts both skeletal muscle and liver function [16].”
BackgroundPathophysiology of type 2 diabetes mellitus
Yki‐Järvinen, H. (2011) · doi:10.1093/med/9780199235292.003.1336 · Cited by 25
Koay, Y. C., Coster, A. C. F., Chen, D. L., Milner, B., Batarseh, A. M., O’Sullivan, J., Greenfield, J. R., & Samocha‐Bonet, D. (2022) · Metabolites · doi:10.3390/metabo12121272 · Cited by 18
“, overnight), despite the presence of hyperinsulinemia [2], and by impaired suppression of endogenous glucose production (EGP, mainly hepatic) in response to insulin rise following meals [2,3].”
BackgroundFízeI'ová, M., Cederberg, H., Stančáková, A., Jauhiainen, R., Vangipurapu, J., Kuusisto, J., & Laakso, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109772 · Cited by 18
Nelson, R. W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4456-5.00008-0 · Cited by 24
Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital
Kumar, B., Mittal, M., Gopalakrishnan, M., Garg, M. K., & Misra, S. (2021) · Endocrine Connections · doi:10.1530/ec-21-0086 · Cited by 20
Ferrannini, E., Baldi, S., Scozzaro, T., Tsimihodimos, V., Tesfaye, F., Shaw, W. C., Rosenthal, N. R., Figtree, G. A., Neal, B. C., Mahaffey, K. W., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2398 · Cited by 20
Self-citationHalldin, M., Brismar, K., Tuvemo, T., & Gustafsson, J. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01656.x · Cited by 17
Hardy, T. A., Henry, R. R., FORRESTER, T. D., Kryzhanovskaya, L., Campbell, G. M., Marks, D. M., & Mudaliar, S. R. D. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01398.x · Cited by 26
“The second step of the clamp procedure produced pharmacological insulin concentrations [35] which generally reflect maximally stimulated glucose utilization in peripheral tissues [33,34].”
BackgroundDavoren, P. M., Kelly, W., Gries, F. A., Hübinger, A., Whately‐Smith, C., & Alberti, K. G. M. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90252-9 · Cited by 17
Predictive Accuracy of Surrogate Indices for Hepatic and Skeletal Muscle Insulin Sensitivity
Muniyappa, R., Tella, S. H., Sortur, S., Mszar, R., Grewal, S., Abel, B. S., Auh, S., Chang, D. C., Krakoff, J., & Skarulis, M. C. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00206 · Cited by 16
Metabolic effects of muraglitazar in type 2 diabetic subjects
Fernandez, M., Gastaldelli, A., Triplitt, C. L., Hardies, J., Casolaro, A., Petz, R., Tantiwong, P., Musi, N., Cersósimo, E., Ferrannini, E., et al. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01429.x · Cited by 17
“Insulin sensitivity was assessed with a 3-h euglycaemic insulin clamp [11,43].”
MethodSelf-citationTrafficking of nonesterified fatty acids in insulin resistance and relationship to dysglycemia
Walker, R. E., Ford, J. L., Boston, R. C., Savinova, O. V., Harris, W. S., Green, M. H., & Shearer, G. C. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00331.2019 · Cited by 17
Metabolic characteristics of autoimmune diabetes mellitus in adults
Groop, L., Eriksson, J. G., Ekstrand, A., Franssila-Kallunki, A., Saloranta, C., & Miettinen, A. (1991) · Diabetologia · doi:10.1007/bf00404024 · Cited by 18
“Studies using 14Cpalmitate to trace NEFA oxidation simultaneousiy with indirect calorimetry have shown, that oxidation of (plasma) NEFA accounts for approximately 2/3 of net lipid oxidation measured by indirect calorimetry [22, 23].”
MethodSelf-citationPioglitazone Increases Whole Body Insulin Sensitivity in Obese, Insulin-Resistant Rhesus Monkeys
Tozzo, E., Bhat, G., Cheon, K., & Camacho, R. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126642 · Cited by 16
“The ability of insulin to stimulate Rd is diminished by ~40% in patients with IGT [21, 22, 30]; while in type 2 diabetic patients it is diminished by ~40–50% [24, 25, 28, 29] in the presence of similar hyperinsulinemic levels achieved in our studies.”
ResultKumar, N., Kaushik, N. K., Park, G., Choi, E. H., & Uhm, H. S. (2013) · Applied Physics Letters · doi:10.1063/1.4828742 · Cited by 16
Deshmukh, A. S., Salehzadeh, F., Métayer, S., Fahlman, R., Nair, K. S., & Al‐Khalili, L. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8818-y · Cited by 16
Insulin Resistance in Adipose Tissue but Not in Liver Is Associated with Aortic Valve Calcification
Galarza, E. J., Posadas‐Romero, C., Torres‐Tamayo, M., Medina-Urrutia, A. X., Rodas-Díaz, M. A., Posadas‐Sánchez, R., Vargas‐Alarcón, G., González-Salazar, M. D. C., Cardoso-Saldaña, G. C., & Juárez-Rojas, J. G. (2016) · Disease Markers · doi:10.1155/2016/9085474 · Cited by 19
“5) [8] or the validated Adipo-IR index (AdipoIR = FFA [mmol/l] × insulin concentration [μIU/L]) [15, 16].”
BackgroundMethodInfluentialThe Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 19
Glass, L. C., Cusi, K. J., Berria, R., Petz, R., Cersósimo, E., DeFronzo, R. A., & Gastaldelli, A. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03811.x · Cited by 16
Self-citationKoopmans, S. J., VanderMeulen, J., Wijdenes, J. W., Corbijn, H., & Dekker, R. A. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-25 · Cited by 18
“For instance, diabetic subjects are hyperglycaemic but show impaired (insulin-stimulated) glucose oxidation and increased NEFA oxidation at elevated plasma NEFA concentrations [1,9,10].”
He, J., Chen, D. L., Samocha‐Bonet, D., Gillinder, K. R., Barclay, J. L., Magor, G. W., Perkins, A. C., Greenfield, J. R., Yang, G., & Whitehead, J. P. (2016) · Growth Factors · doi:10.1080/08977194.2017.1285764 · Cited by 15
Noll, C., Lacraz, G., Ehses, J. A., Coulaud, J., Bailbé, D., Paul, J., Portha, B., Homo‐Delarche, F., & Janel, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.011 · Cited by 15
Insulin resistance in noncirrhotic idiopathic portal hypertension
Petrides, A. S., Riely, C. A., & DeFronzo, R. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90608-n · Cited by 15
Self-citationBruttomesso, D., Fongher, C., Silvestri, B., Barberio, S., Marescotti, M. C., Iori, E., Valerio, A., Crazzolara, D., Pianta, A., Tiengo, A., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00210-2 · Cited by 15
Pelikánová, T., Kohout, M., Baše, J., Štefka, Z., Kovář, J., Kazdová, L., & Válek, J. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90305-v · Cited by 15
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 17
Self-citationMonnier, L., Owens, D. R., & Bolli, G. B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.11.005 · Cited by 16
“[7] Groop LC, Bonadonna RC, Del Prato S, Ratheiser K, Zych K, Ferrannini”
BackgroundWang, Y.-R., Liu, S.-F., Shen, Y., Chen, C.-L., Huang, C.-N., Pan, T., & Wang, C. (2016) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.06.011 · Cited by 14
“[5] Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA.”
BackgroundMcKenzie, B. A., Peloquin, M., Graves, J., Chen, F., Tovar, A. P., Carttar, T. A., Tucker, K., Vo, K., Nelson, M., Super, K. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-89923-z · Cited by 16
Giuseppe, G. D., Ciccarelli, G., CEFALO, C. M. A., Cinti, F., Moffa, S., Impronta, F., Capece, U., Pontecorvi, A., Giaccari, A., & Mezza, T. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03405-9 · Cited by 17
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 16
Self-citationHenry, R. R., Thorburn, A. W., Beerdsen, P., & Gumbiner, B. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.1.e132 · Cited by 14
Mechanism of Free Fatty Acid Effects on Hepatocyte Insulin Receptor Binding and Processing
Hennes, M. M. I., Shrago, E. S., & Kissebah, A. H. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00004.x · Cited by 14
Pathophysiology of Type 2 Diabetes Mellitus
Scheen, A. J., & Lefèbvre, P. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-09127-2_2 · Cited by 23
Carlsson, E., Johansson, L. E., Ström, K., Hoffstedt, J., Groop, L., Holm, C., & Ridderstråle, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803299 · Cited by 14
Self-citationKoška, J., Ortega, E., Bogardus, C., Krakoff, J. A., & Bunt, J. C. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00662.2006 · Cited by 16
Riccio, A., LISATO, G., de Kreutzenberg, S. V., Marchetto, S., Turrin, M., Tiengo, A., & Prato, S. D. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90235-8 · Cited by 14
Ludwig, D. S., Vidal‐Puig, A., O’Brien, R. M., Printz, R. L., Granner, D. K., Moller, D. E., & Flier, J. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.503 · Cited by 16
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch25 · Cited by 37
Self-citationMolecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2
dos Santos, A. A. C., Rodrigues, L. E., Alecrim, A. L., Ferreira, L. D. A., Trettel, C. D. S., Gimenes, G. M., da Silva, A. F., Filho, C. P. B. S., Serdan, T. D. A., Levada‐Pires, A. C., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1037467 · Cited by 19
“In addition to muscle asthenia, patients with severe COVID-19 have increased liver enzyme activity, which may suggest multiple organ failure, especially during cytokine storms (Groop et al., 1989).”
BackgroundStudies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone
Bonora, E., Moghetti, P., Querena, M., Zenere, M. B., Cacciatori, V., Tosi, F., Travia, D., Zoppini, G., & Muggeo, M. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348644 · Cited by 14
Sgarra, L., Addabbo, F., Potenza, M. A., & Montagnani, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00038.2012 · Cited by 13
Pang, J., Xi, C., Jin, J., Han, Y., & Zhang, T. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354474 · Cited by 13
Boer, J. M. A., Feskens, E. J. M., & Kromhout, D. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.2.394 · Cited by 13
Altered degradation of circulating nucleic acids and oligonucleotides in diabetic patients
Kocic, G. M., Bjelaković, G., Saranac, L., Kocić, R., Jevtović−Stoimenov, T., Sokolovic, D. T., Nikolić, G. M., Pavlovic, D. D., & Stojanović, S. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.027 · Cited by 13
Eriksson, J. G., Saloranta, C., Wid�n, E., Ekstrand, A., Franssila-Kallunki, A., Schalin, C., & Groop, P. (1991) · Diabetologia · doi:10.1007/bf00418275 · Cited by 13
Insulin Sensitivity in Septic Cancer‐Bearing Patients
Sauerwein, H. P., Pesola, G. R., Godfried, M. H., Levinson, M., Jeevanandam, M., & Brennan, M. F. (1991) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607191015006653 · Cited by 12
Increased concentrations of glycogen synthase protein in skeletal muscle of patients with NIDDM
Löfman, M., Yki‐Järvinen, H., Parkkonen, M., Lindström, J., Koranyi, L. I., Schalin‐Jäntti, C., & Groop, P. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.1.e27 · Cited by 13
Fatty Acid Metabolism in the Heart Following Diabetes
Lopaschuk, G. D. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-1269-7_10 · Cited by 14
Short Sleep Duration Disrupts Glucose Metabolism: Can Exercise Turn Back the Clock?
Maloney, A., & Kanaley, J. A. (2024) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000339 · Cited by 14
Serum Ferritin Levels Are Associated with Adipose Tissue Dysfunction-Related Indices in Obese Adults
Ding, X., Bian, N., Wang, J., Chang, X., An, Y., Wang, G., & Liu, J. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03198-3 · Cited by 29
“Adipose tissue insulin resistance (adipose-IR) index was obtained using the formula: FINS (pmol/L) × FFA (mmol/L) [18].”
MethodLee, W., Ham, J., Kwon, H. C., Yoon, G., Bae, G., Kim, Y. K., & Kim, S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2227 · Cited by 12
“T2DM patients also manifest adipocyte resistance to the antilipolytic effects of insulin (7,8).”
Suleiman, N., Alkasem, M., Hassoun, S., Abdalhakam, I., Bettahi, I., Mir, F. A., Ramanjaneya, M., Jerobin, J., Iskandarani, A., Samra, T. A., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002039 · Cited by 12
Bahijri, S., & Alissa, E. M. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.10-148 · Cited by 11
Impact of rural-urban environment on metabolic profile and response to a 5-day high-fat diet
Tahapary, D. L., de Ruiter, K., Kurniawan, F., Djuardi, Y., Wang, Y., Nurdin, S. M. E., Iskandar, E., Minggu, D., Yunir, E., Guigas, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25092-6 · Cited by 12
Kim, Y. Y., Kang, H. J., Ko, S. K., & Chung, S. H. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02977015 · Cited by 12
Effect of lipid oxidation on the regulation of glucose utilization in obese patients
Golay, A., Felber, J. P., Jallut, D., Munger, R., Ruíz, J., & J�quier, E. (1995) · Acta Diabetologica · doi:10.1007/bf00581044 · Cited by 13
“demic patients are elevation of the plasma free fatty acid (FFA) concentrations and increased lipid oxidation [6-8].”
BackgroundMartin, C., Odeon, M., Cohen, R., & Beylot, M. (1991) · Metabolism · doi:10.1016/0026-0495(91)90154-o · Cited by 12
Whitelaw, D. C., & Gilbey, S. G. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500501 · Cited by 18
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch17 · Cited by 23
Kiya, M., Tamura, Y., Takeno, K., Someya, Y., Kakehi, S., Sato, M., Yamasaki, N., Kadowaki, S., Suzuki, R., Furukawa, Y., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab037 · Cited by 14
Mitochondria as a target for exercise-mitigated type 2 diabetes
Tian, J., Fan, J., & Zhang, T. (2023) · Journal of Molecular Histology · doi:10.1007/s10735-023-10158-1 · Cited by 13
“It is widely recognized that the essence of T2DM is insulin resistance which mainly occurs in insulin-responsive tissues such as skeletal muscle, liver and adipose tissue (Groop et al. 1989).”
BackgroundThe 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes
Mertens, J., Roosens, L., Braspenning, R., Vandebeeck, J., Francque, S., & Block, C. E. M. D. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae175 · Cited by 10
Bonadonna, R. C., & Stefani, P. (2006) · Cited by 11
Self-citationPathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 13
Self-citationCaruso, M., Miele, C., Oliva, A. C. P., Condorelli, G., Oriente, F., Riccardi, G., Capaldo, B., Fiory, F., Accili, D., Formisano, P., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1194 · Cited by 11
“To evaluate hepatic insulin sensitivity, a dose-response study for the suppressive effect of insulin on hepatic glucose production (HGP) was performed as described (23).”
MethodRetractedTraianedes, K., Proietto, J., & O’Dea, K. (1992) · Metabolism · doi:10.1016/0026-0495(92)90165-7 · Cited by 11
Combination Therapy in Type 2 Diabetes
Bajaj, M., & DeFronzo, R. A. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0613 · Cited by 11
Self-citationSecretion of Insulin in Response to Diet and Hormones
(2), E. M. (. A. M. D. B. (2016) · doi:10.3998/panc.2016.3 · Cited by 27
“subsequent free fatty acid release (29).”
Clusterin is closely associated with adipose tissue insulin resistance
Wang, Y., Yu, H., Ma, X., Wang, Y., Liu, W., Zhang, H., Chen, W., Song, Y., Bao, Y., & Yang, Y. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3688 · Cited by 11
“25 However, this method is expensive, time ‐ consuming, and invasive, thereby limiting its applicability.”
MethodÉtiologie et physiopathologie du diabète de type 2
Rigalleau, V., Lang, J., & Gin, H. (2007) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(07)46586-6 · Cited by 20
Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Giannopoulos, C., Tzima, I. G., Tentolouris, N., & Vasileiadis, I. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230216112032 · Cited by 14
Oxidative Stress in Type 2 Diabetes Mellitus
Abdul‐Ghani, M. A., & DeFronzo, R. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-420-9_11 · Cited by 19
“In adipocytes, insulin stimulates glucose uptake and retards lipolysis by inhibiting hormone-sensitive lipase, thereby restraining the release of free fatty acids (FFA) from adipocytes [ 21 ].”
BackgroundInfluentialSelf-citationVardeny, O., Nicholas, G., Andrei, A., Buhr, K. A., Hermanson, M. P., Moran, J. J. M., Detry, M. A., & Stein, J. H. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.54 · Cited by 10
Mecanismos cirúrgicos de controle do diabetes mellitus tipo 2 após cirurgia bariátrica
Martins, M. V. D. D. C., & de Souza, A. A. P. (2007) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912007000500013 · Cited by 14
“Peptide YY(1-36) and Peptide YY(3-36): Part I.”
The color of fat and its central role in the development and progression of metabolic diseases
Gaggini, M., Carli, F., & Gastaldelli, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0060 · Cited by 12
“[59] showed that the suppression of FFAs during insulin infusion follows a hyperbolic shape.”
BackgroundMethodGómez-Sámano, M. Á., Gulías-Herrero, A., Ramos, D. C., Brau-Figueroa, H., Mehta, R., Vargas-Gutiérrez, D., Meza-Arana, C. E., Nieves-Niebla, J. M., & Vázquez-Hernández, M. O. (2011) · Endocrine Practice · doi:10.4158/ep11072.or · Cited by 10
Effects of different lipid substrates on glucose metabolism in normal postabsorptive humans
Broussolle, C., Beylot, M., CHASSARD, D., & Beaufrère, B. (1992) · Metabolism · doi:10.1016/0026-0495(92)90096-s · Cited by 10
Evidence that hyperglycaemia per se does not inhibit hepatic glucose production in man
M�ller, M. J., Acheson, K. J., Burger, A., & Jéquier, E. (1990) · European Journal of Applied Physiology · doi:10.1007/bf00379399 · Cited by 10
“A positive correlation has been reported between plasma FFA and R~ suggesting that FFA augment endogenous Ra ( Groop et al. 1989 ).”
Habito, R. C., Barnett, M. R., Yamamoto, A., Cameron‐Smith, D., O’Dea, K., Zimmet, P., & Collier, G. (1995) · Acta Diabetologica · doi:10.1007/bf00838490 · Cited by 12
Lucidi, P., Perriello, G., Porcellati, F., Pampanelli, S., Fano, M. D., Tura, A., Bolli, G. B., & Fanelli, C. G. (2023) · Diabetes · doi:10.2337/db22-0721 · Cited by 20
Advancements in research on the association between the biological CLOCK and type 2 diabetes
Cheng, H., Zhong, D., Tan, Y., Huang, M., Xijie, S., Pan, H., Yang, Z., Huang, F., Li, F., & Tang, Q. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1320605 · Cited by 11
Metadata
- Authors
- Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- University of Helsinki (FI)
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 205-213
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303971
- OpenAlex
- W1981456793
- Cited by
- 812
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 28 · 2023: 15 · 2022: 27 · 2021: 30 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 32 · 2016: 26 · 2015: 22 · 2014: 22 · 2013: 26 · 2012: 26
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- Fogarty International Center (F05-TWO-3451)
- National Center for Research Resources (RR 125)
- Ministero dell'Istruzione e del Merito
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- type 2 diabetes, insulin resistance, glucose metabolism, free fatty acid metabolism, hepatic glucose production, glucose oxidation, nonoxidative glucose metabolism, fatty acid oxidation, fatty acid re-esterification, hyperinsulinemia, insulin clamp, lipid oxidation
- MeSH terms
- Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Oxidation-Reduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.